A Preclinical Evaluation of the Antitumor Activities of Edible and Medicinal Mushrooms: A Molecular Insight.
A Preclinical Evaluation of the Antitumor Activities of Edible and Medicinal Mushrooms: A Molecular Insight.
复制标题
DOI:
10.1177/1534735417736861
复制
发表时间:
2018-06
影响因子:
2.9
通讯作者:
Huang M
中科院分区:
文献类型:
--
作者:
Joseph TP;Chanda W;Padhiar AA;Batool S;LiQun S;Zhong M;Huang M
Cancer is the leading cause of morbidity and mortality around the globe. For certain types of cancer, chemotherapy drugs have been extensively used for treatment. However, severe side effects and the development of resistance are the drawbacks of these agents. Therefore, development of new agents with no or minimal side effects is of utmost importance. In this regard, natural compounds are well recognized as drugs in several human ailments, including cancer. One class of fungi, “mushrooms,” contains numerous compounds that exhibit interesting biological activities, including antitumor activity. Many researchers, including our own group, are focusing on the anticancer potential of different mushrooms and the underlying molecular mechanism behind their action. The aim of this review is to discuss PI3K/AKT, Wnt-CTNNB1, and NF-κB signaling pathways, the occurrence of genetic alterations in them, the association of these aberrations with different human cancers and how different nodes of these pathways are targeted by various substances of mushroom origin. We have given evidence to propose the therapeutic attributes and possible mode of molecular actions of various mushroom-originated compounds. However, anticancer effects were typically demonstrated in in vitro and in vivo models and very limited number of studies have been conducted in the human population. It is our belief that this review will help the research community in designing concrete preclinical and clinical studies to test the anticancer potential of mushroom-originated compounds on different cancers harboring particular genetic alteration(s).
登录
查看更多内容
影响因子:
4.1
作者:
Dias DA;Urban S;Roessner U
通讯作者:
Roessner U
影响因子:
5.6
作者:
Erkel, G.;Wisser, G.;Anke, T.
通讯作者:
Anke, T.
影响因子:
--
作者:
Das, Arabinda;Miller, Rickey;Lee, Philip;Holden, Chrysanthe Alyssa;Lindhorst, Scott M.;Jaboin, Jerry;Vandergrift, William A., III;Banik, Naren L.;Giglio, Pierre;Varma, Abhay K.;Raizer, Jeffery J.;Patel, Sunil J.
通讯作者:
Patel, Sunil J.
影响因子:
64.8
作者:
Ding, Li;Getz, Gad;Wheeler, David A.;Mardis, Elaine R.;McLellan, Michael D.;Cibulskis, Kristian;Sougnez, Carrie;Greulich, Heidi;Muzny, Donna M.;Morgan, Margaret B.;Fulton, Lucinda;Fulton, Robert S.;Zhang, Qunyuan;Wendl, Michael C.;Lawrence, Michael S.;Larson, David E.;Chen, Ken;Dooling, David J.;Sabo, Aniko;Hawes, Alicia C.;Shen, Hua;Jhangiani, Shalini N.;Lewis, Lora R.;Hall, Otis;Zhu, Yiming;Mathew, Tittu;Ren, Yanru;Yao, Jiqiang;Scherer, Steven E.;Clerc, Kerstin;Metcalf, Ginger A.;Ng, Brian;Milosavljevic, Aleksandar;Gonzalez-Garay, Manuel L.;Osborne, John R.;Meyer, Rick;Shi, Xiaoqi;Tang, Yuzhu;Koboldt, Daniel C.;Lin, Ling;Abbott, Rachel;Miner, Tracie L.;Pohl, Craig;Fewell, Ginger;Haipek, Carrie;Schmidt, Heather;Dunford-Shore, Brian H.;Kraja, Aldi;Crosby, Seth D.;Sawyer, Christopher S.;Vickery, Tammi;Sander, Sacha;Robinson, Jody;Winckler, Wendy;Baldwin, Jennifer;Chirieac, Lucian R.;Dutt, Amit;Fennell, Tim;Hanna, Megan;Johnson, Bruce E.;Onofrio, Robert C.;Thomas, Roman K.;Tonon, Giovanni;Weir, Barbara A.;Zhao, Xiaojun;Ziaugra, Liuda;Zody, Michael C.;Giordano, Thomas;Orringer, Mark B.;Roth, Jack A.;Spitz, Margaret R.;Wistuba, Ignacio I.;Ozenberger, Bradley;Good, Peter J.;Chang, Andrew C.;Beer, David G.;Watson, Mark A.;Ladanyi, Marc;Broderick, Stephen;Yoshizawa, Akihiko;Travis, William D.;Pao, William;Province, Michael A.;Weinstock, George M.;Varmus, Harold E.;Gabriel, Stacey B.;Lander, Eric S.;Gibbs, Richard A.;Meyerson, Matthew;Wilson, Richard K.
通讯作者:
Wilson, Richard K.
影响因子:
64.5
作者:
Grivennikov SI;Greten FR;Karin M
通讯作者:
Karin M